The novel coronavirus (COVID-19) pandemic has created an unprecedented global health crisis, affecting millions of people around the world. While the virus is primarily known for its respiratory symptoms, it has been linked to a variety of other health issues, including constipation. This article will explore the unseen side effect of COVID-19 on constipation and provide tips for doctors on how to manage this symptom in their patients.
Constipation is a common digestive issue characterized by infrequent or difficult bowel movements. It is usually caused by a diet that is low in fiber or fluids, lack of physical activity, certain medications, or medical conditions such as irritable bowel syndrome (IBS). Symptoms of constipation include abdominal pain, bloating, feeling of incomplete evacuation, and straining during bowel movements.
Recent research has found that constipation is a common symptom of COVID-19. A study conducted by the University of Oxford found that up to one-third of COVID-19 patients reported constipation as a symptom. It is believed that the virus affects the digestive system, which can lead to constipation. Additionally, the stress and anxiety caused by the pandemic can also contribute to constipation.
Certain groups of people are at an increased risk for developing constipation due to COVID-19. Older adults are more likely to experience constipation due to age-related changes in the digestive system. People with underlying medical conditions such as diabetes, heart disease, or kidney disease are also at an increased risk. Additionally, people who are taking medications such as opioids or antidepressants may be more likely to experience constipation.
Doctors should advise their patients on how to manage constipation due to COVID-19. The first step is to make sure the patient is drinking enough fluids and eating a diet that is high in fiber. Additionally, the patient should be encouraged to get regular physical activity, even if it is just taking a walk around the block. If these lifestyle changes are not enough to relieve constipation, doctors may prescribe medications such as laxatives or fiber supplements. It is important to note that these medications should only be used as a last resort, as overuse can lead to dependency or other side effects.
COVID-19 is associated with a variety of unseen side effects, including constipation. Doctors should be aware of this symptom in their patients and provide advice on how to manage it. This includes encouraging a healthy diet, adequate hydration, and regular physical activity. If these measures are not enough, medications such as laxatives or fiber supplements may be prescribed. By addressing this symptom, doctors can help their patients manage their constipation and improve their overall health.
1.
Examines Office-Based Transperineal Prostate Biopsies Methodology.
2.
A global study demonstrates that screening for lung cancer significantly raises the long-term survival rate.
3.
Is a $2,000 Whole-Body MRI Worth It?
4.
Surgery may not be necessary to treat invasive breast cancer
5.
Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.
1.
Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options
2.
Understanding Sepsis and Precision-Medicine-Based Immunotherapy: A Pathophysiological Perspective
3.
Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know
4.
Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post
5.
Understanding Lymphedema: Symptoms, Causes, and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
4.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation